The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Canagliflozin exerts anti-inflammatory effects by inhibiting intracellular glucose metabolism and promoting autophagy in immune cells
Abstract
Graphical abstract Figure. No Caption available. ABSTRACT Canagliflozin (CAN) regulates intracellular glucose metabolism by targeting sodium‐glucose co‐transporter 2 (SGLT2) and intracellular glucose metabolism affects inflammation. In this study, we hypothesized that CAN might exert anti‐inflammatory effects. The anti‐inflammatory effects and action mechanisms of CAN were assayed in lipopolysaccharide (LPS)‐induced RAW264.7 and THP‐1 cells and NIH mice. Results showed that CAN significantly inhibited the production and release of interleukin (IL)‐1, IL‐6, or tumor necrosis factor‐&agr; (TNF‐&agr;) in the LPS‐induced RAW264.7 and THP‐1 cells, and mice. CAN also significantly inhibited intracellular glucose metabolism and 6‐phosphofructo‐2‐kinase (PFK2) expression. CAN increased the levels of sequestosome‐1 (SQSTM1/p62), upregulated the ratios of microtubule‐associated protein 1A/1B‐light chain 3 (LC3) II to I, promoted the formation of LC3 puncta, and enhanced the activities of lysosome. The inhibition of autophagy by 3‐methyladenine (3‐MA) reversed the effects of CAN on IL‐1&agr; levels. Increased autophagy might be associated with increased AMP‐activated protein kinase (AMPK) phosphorylation. Interestingly, p62 demonstrated good co‐localization with IL‐1&agr; and possibly mediated IL‐1&agr; degradation. CAN‐induced increase in p62 was dependent on the nuclear factor kappa B (NF&kgr;B) signaling pathway. These results indicated that CAN might exert anti‐inflammatory effects by inhibiting intracellular glucose metabolism and promoting autophagy. Attenuated glucose metabolism by PFK2, increased autophagy flow by AMPK, and increased p62 levels by NF&kgr;B might be responsible for the molecular mechanisms of CAN. This drug might serve as a new promising anti‐inflammatory drug for acute or chronic inflammatory diseases via independent hypoglycemic mechanisms. This drug might also be used as an important reference for similar drug research and development by targeting intracellular glucose metabolism and autophagy in immune cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
Metabolic reprogramming in macrophages and dendritic cells in innate immunity
Kelly, B., & O'Neill, L. A. (2015) · Cell Research · doi:10.1038/cr.2015.68 · Cited by 1,876
Biology of Human Sodium Glucose Transporters
Wright, E. M., Loo, D. D. F., & Hirayama, B. A. (2011) · Physiological Reviews · doi:10.1152/physrev.00055.2009 · Cited by 1,430
Wu, Y.-T., Tan, H.-L., Shui, G., Bauvy, C., Huang, Q., Wenk, M. R., Ong, C.-N., Codogno, P., & Shen, H.-M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.080796 · Cited by 1,127
Fujita, K.-I., & Srinivasula, S. M. (2011) · Autophagy · doi:10.4161/auto.7.5.15101 · Cited by 65
Yang, Z., Zeng, B., Pan, Y., Huang, P., & Wang, C. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.10.070 · Cited by 48
Cited by
Autophagy in metabolic disease and ageing
Kitada, M., & Koya, D. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00551-9 · Cited by 399
Targeting inflammation to treat diabetic kidney disease: the road to 2030
Rayego-Mateos, S., Rodrigues-Diez, R. R., Fernandez-Fernandez, B., Mora-Fernández, C., Marchant, V., Donate-Correa, J., Navarro-González, J. F., Ortiz, A., & Ruiz-Ortega, M. (2023) · Kidney International · doi:10.1016/j.kint.2022.10.030 · Cited by 366
Nasiri-Ansari, N., Nikolopoulou, C., Papoutsi, K., Kyrou, I., Mantzoros, C. S., Kyriakopoulos, G., Chatzigeorgiou, A., Kalotychou, V., Randeva, M. S., Chatha, K., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020818 · Cited by 297
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors
Salvatore, T., Galiero, R., Caturano, A., Rinaldi, L., Di Martino, A., Albanese, G., Di Salvo, J., Epifani, R., Marfella, R., Docimo, G., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073651 · Cited by 256
Metadata
- Authors
- Xu, C., Wang, W., Zhong, J., Lei, F., Xu, N., Zhang, Y., & Xie, W.
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 152
- Pages
- 45-59
- ISSN
- 0006-2952 (ISSN-L)
- OpenAlex
- W2790864824
- Cited by
- 161
- References
- 6
- FWCI
- 11.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Canagliflozin exerts anti-inflammatory effects by inhibiting intracellular glucose metabolism and promoting autophagy in immune cells. https://app.cochat.ai/papers/10.1016/j.bcp.2018.03.013
- The paper
- Xu, C., Wang, W., Zhong, J., Lei, F., Xu, N., Zhang, Y., & Xie, W. (2018). Canagliflozin exerts anti-inflammatory effects by inhibiting intracellular glucose metabolism and promoting autophagy in immune cells. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2018.03.013
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.